
TSI GROUP CO., LTD. — Investor Relations & Filings
TSI Group Co., Ltd. is a global developer and manufacturer of functional ingredients and finished dosage forms for the dietary supplement, pharmaceutical, and food and beverage sectors. The company specializes in the research, development, and large-scale production of high-quality bioactive compounds. Key product categories include joint health ingredients such as glucosamine and chondroitin, as well as proprietary muscle health and metabolic health solutions like HMB and PEAK ATP. TSI Group maintains advanced manufacturing facilities and quality control systems to ensure compliance with international standards. The organization focuses on providing science-based ingredients supported by clinical research to global brand owners and manufacturers. Its core capabilities span from raw material sourcing and chemical synthesis to specialized formulation and finished product manufacturing.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 技源集团股份有限公司对外提供财务资助管理制度 | 2025-08-29 | Chinese | |
| 技源集团股份有限公司对外投资管理制度(2025年8月修订) | 2025-08-29 | Chinese | |
| 技源集团股份有限公司董事会提名委员会议事规则(2025年8月修订) | 2025-08-29 | Chinese | |
| 技源集团股份有限公司董事会战略委员会议事规则(2025年8月修订) | 2025-08-29 | Chinese | |
| 技源集团股份有限公司董事会议事规则(2025年8月修订) | 2025-08-29 | Chinese | |
| 技源集团股份有限公司第二届董事会第五次会议决议公告 | 2025-08-29 | Chinese |
Browse filings by year
2 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 39593089 | 技源集团股份有限公司对外提供财务资助管理制度 | 2025-08-29 | Chinese | ||
| 39593084 | 技源集团股份有限公司对外投资管理制度(2025年8月修订) | 2025-08-29 | Chinese | ||
| 39593078 | 技源集团股份有限公司董事会提名委员会议事规则(2025年8月修订) | 2025-08-29 | Chinese | ||
| 39593072 | 技源集团股份有限公司董事会战略委员会议事规则(2025年8月修订) | 2025-08-29 | Chinese | ||
| 39593067 | 技源集团股份有限公司董事会议事规则(2025年8月修订) | 2025-08-29 | Chinese | ||
| 39593060 | 技源集团股份有限公司第二届董事会第五次会议决议公告 | 2025-08-29 | Chinese | ||
| 39593044 | 关于使用自有资金、银行承兑汇票等方式支付募投项目部分款项并以募集资金等额置换的公告 | 2025-08-13 | Chinese | ||
| 39593035 | 东方证券股份有限公司关于技源集团股份有限公司调整部分募投项目金额的核查意见 | 2025-08-13 | Chinese | ||
| 39593030 | 第二届董事会第四次会议决议公告 | 2025-08-13 | Chinese | ||
| 39593027 | 东方证券股份有限公司关于技源集团股份有限公司使用自有资金、银行承兑汇票等方式支付募投项目部分款项并以募集资金等额置换的核查意见 | 2025-08-13 | Chinese | ||
| 39593021 | 关于使用部分闲置募集资金进行现金管理的公告 | 2025-08-13 | Chinese | ||
| 39593016 | 技源集团股份有限公司募集资金置换专项鉴证报告 | 2025-08-13 | Chinese | ||
| 39592957 | 东方证券股份有限公司关于技源集团股份有限公司使用募集资金向全资子公司增资或借款以实施募投项目的核查意见 | 2025-08-13 | Chinese | ||
| 39592937 | 东方证券股份有限公司关于技源集团股份有限公司使用部分闲置募集资金进行现金管理的核查意见 | 2025-08-13 | Chinese | ||
| 39592929 | 第二届监事会第三次会议决议公告 | 2025-08-13 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
TSI GROUP CO., LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/57547/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=57547 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=57547 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=57547 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 57547}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for TSI GROUP CO., LTD. (id: 57547)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.